These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7588024)

  • 1. [Treatment of myelodysplastic syndromes aside from clinical studies].
    Lengfelder E; Hehlmann R
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1527. PubMed ID: 7588024
    [No Abstract]   [Full Text] [Related]  

  • 2. Danazol therapy in myelodysplastic syndromes.
    Pozzato G; Franzin F; Moretti M; Campanacci L
    Haematologica; 1992; 77(1):96. PubMed ID: 1398293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
    Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
    Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndromes: disease overview and therapy options.
    Coutré S
    Manag Care; 2008 Jul; 17(7 Suppl 6):3-8. PubMed ID: 19093333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anemia in the elderly patient. Is it a myelodysplastic syndrome?].
    MMW Fortschr Med; 2012 Feb; 154(3):26. PubMed ID: 22458163
    [No Abstract]   [Full Text] [Related]  

  • 6. Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy.
    Damaj G; Lefrère F; Canioni D; Rubio MT; Radford-Weiss I; Valensi F; Varet B; Hermine O
    Eur J Haematol; 2002 Apr; 68(4):233-5. PubMed ID: 12071939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life.
    Balducci L
    Cancer; 2006 May; 106(10):2087-94. PubMed ID: 16607649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of myelodysplastic syndrome (MDS)].
    Kawano F
    Rinsho Ketsueki; 1986 Aug; 27(8):1476-81. PubMed ID: 3795518
    [No Abstract]   [Full Text] [Related]  

  • 9. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
    Chan G; DiVenuti G; Miller K
    Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplasia in the Wellington region 2002-2007: disease incidence and treatment patterns.
    Irwin J; D'Souza A; Johnson L; Carter J
    Intern Med J; 2011 May; 41(5):399-407. PubMed ID: 21299783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical roundtable monograph. MDS classification and risk stratification.
    Shammo JM
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):S8-12. PubMed ID: 19731465
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic factors in myelodysplastic syndromes.
    Bernasconi C
    Hematol Oncol; 1993; 11 Suppl 1():20-6. PubMed ID: 8486337
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelodysplastic syndromes clinical practice guidelines in oncology.
    Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):58-77. PubMed ID: 16403405
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anaphylaxis in a myelodysplastic syndrome patient during platelet transfusion with a leukocyte-reduction filter].
    Uoshima N; Akaogi T; Hayashi H; Kobayashi Y; Kondo M
    Rinsho Ketsueki; 1998 Aug; 39(8):614-6. PubMed ID: 9785982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E; Malcovati L
    Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myeloproliferative syndromes].
    Ganser A
    Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
    Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
    Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statement on iron overload in myelodysplastic syndromes.
    Bennett JM;
    Am J Hematol; 2008 Nov; 83(11):858-61. PubMed ID: 18767130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is survival enough for myelodysplastic syndromes?
    Santini V
    Leuk Res; 2009 Aug; 33(8):1017-8. PubMed ID: 19268362
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.